• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RANGER PACLITAXEL-COATED PTA BALLOON CATHETER; DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER Back to Search Results
Model Number 1973-03
Device Problems Difficult to Remove (1528); Failure to Deflate (4060)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/07/2024
Event Type  malfunction  
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6).
 
Event Description
It was reported that the balloon failed to deflate and was difficult to remove.The 95% stenosed target lesion was located in moderately tortuous and severely calcified artery.A 6.0 x 60mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for endovascular therapy procedure.During the procedure, the balloon was initially inflated at nominal pressure for 180 seconds.Upon deflation, the balloon did not completely deflate.The balloon was attempted to be deflated for 10 seconds, and upon removal, resistance occurred.The entire system was then removed, and the procedure was completed.No complications were reported.
 
Event Description
It was reported that the balloon failed to deflate and was difficult to remove.The 95% stenosed target lesion was located in moderately tortuous and severely calcified artery.A 6.0 x 60mm, 135cm ranger paclitaxel-coated pta balloon catheter was selected for endovascular therapy procedure.During the procedure, the balloon was initially inflated at nominal pressure for 180 seconds.Upon deflation, the balloon did not completely deflate.The balloon was attempted to be deflated for 10 seconds, and upon removal, resistance occurred.The entire system was then removed, and the procedure was completed.No complications were reported.
 
Manufacturer Narrative
E1 - initial reporter facility name: (b)(6).Device evaluated by mfr.: the device was returned for analysis.A visual examination of the returned device found that the balloon had been inflated and was not refolded.It is not known when the balloon was subjected to positive pressure.The balloon was pulled in a distal direction over the distal tip.The investigator was unable to inflate the balloon due to the damage of the polymer extrusion.The markerbands and tip section of the device were visually examined, and no issues were noted with the markerbands or tip of the device.A visual and tactile examination of the polymer extrusion found multiple kinks.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RANGER PACLITAXEL-COATED PTA BALLOON CATHETER
Type of Device
DRUG-ELUTING PERIPHERAL TRANSLUMINAL ANGIOPLASTY CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
HEMOTEQ AG
adenauerstrasse 15
wuerselen 52146
GM   52146
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18908671
MDR Text Key337741154
Report Number2124215-2024-14333
Device Sequence Number1
Product Code ONU
UDI-Device Identifier08714729976103
UDI-Public08714729976103
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P190019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/17/2024
Device Model Number1973-03
Device Catalogue Number1973-03
Device Lot Number04077H22
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/26/2024
Initial Date FDA Received03/14/2024
Supplement Dates Manufacturer Received03/26/2024
Supplement Dates FDA Received04/16/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/18/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-